{"id":986902,"date":"2026-07-29T20:03:42","date_gmt":"2026-07-30T00:03:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/"},"modified":"2026-07-29T20:03:42","modified_gmt":"2026-07-30T00:03:42","slug":"capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/","title":{"rendered":"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Capricor investors lost 60% to 70% after FDA briefing documents challenged the Company’s claims that Deramiocel demonstrated statistically significant benefits.<\/i>\n <\/p>\n

\n NEW YORK<\/span>, July 29, 2026<\/span> \/PRNewswire\/ — Capricor (NASDAQ: CAPR) investors were hit with a 60% to 70% drop on July 27, 2026, after FDA briefing documents concluded that Deramiocel failed to demonstrate statistically significant benefits on its pre-specified cardiac endpoint. Shareholders who lost money on CAPR are encouraged to act now as Levi & Korsinsky reviews potential securities law violations. Submit loss information now<\/a>\u00a0or call (212) 363-7500.<\/p>\n

\n

\n \"Levi\n <\/p>\n<\/p><\/div>\n

The investor impact centers on Deramiocel’s cardiac efficacy data. In a May 7, 2026 press release, Capricor stated that Deramiocel slowed cardiac decline by approximately 91% compared to placebo, with statistical significance.<\/p>\n

The July 27, 2026 FDA briefing documents addressed the same cardiac endpoint and concluded that the pivotal trial failed to demonstrate statistically significant benefit under the pre-specified analysis. CAPR shares fell approximately 60% to 70% after the documents became public ahead of the July 29, 2026 advisory committee meeting.<\/p>\n

Levi & Korsinsky is reviewing losses suffered by CAPR investors tied to the July 27, 2026 decline and the Company’s prior statements concerning Deramiocel’s cardiac efficacy.<\/p>\n

If you suffered losses in Capricor, request your loss review today<\/a>\u00a0or call (212) 363-7500.<\/p>\n

\n Levi & Korsinsky, LLP<\/b>\u00a0— Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.<\/p>\n

Frequently Asked Questions About the CAPR Investigation<\/p>\n

\n Q: Who is eligible to participate in the CAPR investigation?<\/b>A: Investors who purchased CAPR stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.<\/p>\n

\n Q: How much did CAPR stock drop?<\/b>A: CAPR shares fell approximately 60% to 70% after FDA briefing documents concluded that Deramiocel had not demonstrated substantial evidence of effectiveness, including on its pre-specified cardiac endpoint.<\/p>\n

\n Q: Which statements are being investigated as potentially misleading?<\/b>A: The investigation concerns whether Capricor made materially false or misleading statements regarding Deramiocel’s cardiac efficacy, including statements that the therapy slowed cardiac decline by approximately 91% compared to placebo with statistical significance.<\/p>\n

\n Q: What is a lead plaintiff and why does it matter?<\/b>A: If the investigation proceeds to legal action, a lead plaintiff is the investor the court appoints to represent affected investors. Lead plaintiffs are typically investors with the largest documented losses.<\/p>\n

\n Q: What documents do I need to participate?<\/b>A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any sale dates and prices.<\/p>\n

\n Q: What if I already sold my CAPR shares — can I still recover losses?<\/b>A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought CAPR and sold at a loss may still participate in the investigation.<\/p>\n

\n Q: Do I need to go to court or give testimony?<\/b>A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, most affected investors do not appear in court.<\/p>\n

\n Q: What does it cost me to participate?<\/b>A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis, with no upfront fees, retainer, or out-of-pocket costs.<\/p>\n

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com<\/a>
Tel: (212) 363-7500
Fax: (212) 363-7171<\/p>\n

Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/capricor-investigation-notice-levi–korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr-302838240.html<\/a><\/p>\n

SOURCE Levi & Korsinsky, LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire Capricor investors lost 60% to 70% after FDA briefing documents challenged the Company’s claims that Deramiocel demonstrated statistically significant benefits. NEW YORK, July 29, 2026 \/PRNewswire\/ — Capricor (NASDAQ: CAPR) investors were hit with a 60% to 70% drop on July 27, 2026, after FDA briefing documents concluded that Deramiocel failed to demonstrate statistically significant benefits on its pre-specified cardiac endpoint. Shareholders who lost money on CAPR are encouraged to act now as Levi & Korsinsky reviews potential securities law violations. Submit loss information now\u00a0or call (212) 363-7500. The investor impact centers on Deramiocel’s cardiac efficacy data. In a May 7, 2026 press release, Capricor stated that Deramiocel slowed cardiac decline by approximately 91% compared to placebo, with … <\/p>\n

Continue reading “Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-986902","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCapricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Capricor investors lost 60% to 70% after FDA briefing documents challenged the Company’s claims that Deramiocel demonstrated statistically significant benefits. NEW YORK, July 29, 2026 \/PRNewswire\/ — Capricor (NASDAQ: CAPR) investors were hit with a 60% to 70% drop on July 27, 2026, after FDA briefing documents concluded that Deramiocel failed to demonstrate statistically significant benefits on its pre-specified cardiac endpoint. Shareholders who lost money on CAPR are encouraged to act now as Levi & Korsinsky reviews potential securities law violations. Submit loss information now\u00a0or call (212) 363-7500. The investor impact centers on Deramiocel’s cardiac efficacy data. In a May 7, 2026 press release, Capricor stated that Deramiocel slowed cardiac decline by approximately 91% compared to placebo, with … Continue reading "Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-30T00:03:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS650751\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)\",\"datePublished\":\"2026-07-30T00:03:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/\"},\"wordCount\":590,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650751\\\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/\",\"name\":\"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650751\\\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112\",\"datePublished\":\"2026-07-30T00:03:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650751\\\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650751\\\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/","og_locale":"en_US","og_type":"article","og_title":"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR) - Market Newsdesk","og_description":"PR Newswire Capricor investors lost 60% to 70% after FDA briefing documents challenged the Company’s claims that Deramiocel demonstrated statistically significant benefits. NEW YORK, July 29, 2026 \/PRNewswire\/ — Capricor (NASDAQ: CAPR) investors were hit with a 60% to 70% drop on July 27, 2026, after FDA briefing documents concluded that Deramiocel failed to demonstrate statistically significant benefits on its pre-specified cardiac endpoint. Shareholders who lost money on CAPR are encouraged to act now as Levi & Korsinsky reviews potential securities law violations. Submit loss information now\u00a0or call (212) 363-7500. The investor impact centers on Deramiocel’s cardiac efficacy data. In a May 7, 2026 press release, Capricor stated that Deramiocel slowed cardiac decline by approximately 91% compared to placebo, with … Continue reading \"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-30T00:03:42+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS650751\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)","datePublished":"2026-07-30T00:03:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/"},"wordCount":590,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS650751\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/","name":"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS650751\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112","datePublished":"2026-07-30T00:03:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS650751\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS650751\/Levi-and-Korsinsky-Logo.jpg?id=OA2802112"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-investigation-notice-levi-korsinsky-notifies-investors-of-pending-investigation-into-capricor-capr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Capricor Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Capricor (CAPR)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/986902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=986902"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/986902\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=986902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=986902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=986902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}